Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs CNI✓SelectedUSD · CNIGSK vs CNI performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs CNI

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+42.8%
CNI return
+8.7%
Excess return
+34.2%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioCNIExcessAlpha
1D-1.3%-0.9%-0.4%-1.1%
7D-3.1%-1.8%-1.3%-2.6%
30D-0.9%+4.3%-5.2%-2.0%
3M-4.2%-0.5%-3.7%-4.1%
6M-1.6%+12.5%-14.0%-4.9%
YTD+2.6%+28.9%-26.3%-4.5%
1Y+6.2%+35.6%-29.4%-2.5%
3Y+55.0%+15.6%+39.4%+47.4%
5Y+42.8%+7.0%+35.8%+35.4%
All+42.8%+8.7%+34.2%+35.4%

Cumulative growth

Daily Returns

Daily percentage return beside CNI.

Daily Out/Under-Performance

Portfolio return minus CNI return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CNI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded CNI wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling